Showing results (351-360 of 464) with videos related to
Sort By:
Pageof 47
Oncotarget|November 22, 2017
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatmentMarzia Del Re, Paola Bordi, Iacopo Petrini, et al.Clinical Pharmacology and Therapeutics|February 26, 2014
Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662M H M Diekstra, H J Klümpen, M P J K Lolkema, et al.JCO Precision Oncology|June 8, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant AlleleNiels Heersche, Jonathan E Knikman, Maarten J Deenen, et al.Clinical Pharmacology and Therapeutics|February 21, 2018
Pharmacogenetic Information in Clinical Guidelines: The European PerspectiveJesse J Swen, Marga Nijenhuis, Mandy van Rhenen, et al.JCO Precision Oncology|July 21, 2022
DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse EventsMirjam de With, Gemma Brufau, Laila A van den Berg, et al.Placenta|October 19, 2024
First-trimester maternal tryptophan metabolites, utero-placental (vascular)development and hypertensive disorders of pregnancy: The Rotterdam periconceptional cohortSofie K M van Zundert, Michelle Broekhuizen, Mina Mirzaian, et al.BMJ Open|July 10, 2023
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trialRenske G Kamperman, Johannes A Bogaards, Sanne W Evers, et al.The Journal of Molecular Diagnostics : JMD|June 24, 2023
Characterization of Reference Materials for CYP3A4 and CYP3A5: A (GeT-RM) Collaborative ProjectAndrea Gaedigk, Erin C Boone, Amy J Turner, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 2010
Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathyK Kuitwaard, L H van den Berg, M Vermeulen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platformAnne-Joy M de Graan, Laure Elens, Marcel Smid, et al.Pageof 47